Matches in Nanopublications for { ?s ?p "[Leukocyte infiltration and tumor angiogenesis were assessed by immunohistochemistry with antibodies against neutrophil (Gr-1, 7/4) or macrophage-specific antigens (CD68, F4-80) and the vascular endothelial cell marker CD31, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP431974.RASCL3AifJ39vFwQMIJ9vqTcVaZbTZMLl32zUBZkKUzvk130_assertion description "[Leukocyte infiltration and tumor angiogenesis were assessed by immunohistochemistry with antibodies against neutrophil (Gr-1, 7/4) or macrophage-specific antigens (CD68, F4-80) and the vascular endothelial cell marker CD31, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431974.RASCL3AifJ39vFwQMIJ9vqTcVaZbTZMLl32zUBZkKUzvk130_provenance.
- NP201190.RA69fdsayMFSOOYgMGLpg7nROTbkjNgtcIVAYB-TI7cbY130_assertion description "[Leukocyte infiltration and tumor angiogenesis were assessed by immunohistochemistry with antibodies against neutrophil (Gr-1, 7/4) or macrophage-specific antigens (CD68, F4-80) and the vascular endothelial cell marker CD31, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201190.RA69fdsayMFSOOYgMGLpg7nROTbkjNgtcIVAYB-TI7cbY130_provenance.
- assertion description "[Leukocyte infiltration and tumor angiogenesis were assessed by immunohistochemistry with antibodies against neutrophil (Gr-1, 7/4) or macrophage-specific antigens (CD68, F4-80) and the vascular endothelial cell marker CD31, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Leukocyte infiltration and tumor angiogenesis were assessed by immunohistochemistry with antibodies against neutrophil (Gr-1, 7/4) or macrophage-specific antigens (CD68, F4-80) and the vascular endothelial cell marker CD31, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP615516.RAAA8l56gWQUjx_s6nw10nWtBWi2JRy5Yfis8lvCVckBU130_assertion description "[Leukocyte infiltration and tumor angiogenesis were assessed by immunohistochemistry with antibodies against neutrophil (Gr-1, 7/4) or macrophage-specific antigens (CD68, F4-80) and the vascular endothelial cell marker CD31, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615516.RAAA8l56gWQUjx_s6nw10nWtBWi2JRy5Yfis8lvCVckBU130_provenance.
- NP675493.RAqsR7zPynMHXLlLoj2Vk_vBGVM5WHr8tuhrt-rqVCBHE130_assertion description "[Leukocyte infiltration and tumor angiogenesis were assessed by immunohistochemistry with antibodies against neutrophil (Gr-1, 7/4) or macrophage-specific antigens (CD68, F4-80) and the vascular endothelial cell marker CD31, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675493.RAqsR7zPynMHXLlLoj2Vk_vBGVM5WHr8tuhrt-rqVCBHE130_provenance.
- NP297673.RAHCOEM2nxDvUPqA_PQ6YFRJeRvbzAumPrEaX9H6PqJDQ130_assertion description "[Leukocyte infiltration and tumor angiogenesis were assessed by immunohistochemistry with antibodies against neutrophil (Gr-1, 7/4) or macrophage-specific antigens (CD68, F4-80) and the vascular endothelial cell marker CD31, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297673.RAHCOEM2nxDvUPqA_PQ6YFRJeRvbzAumPrEaX9H6PqJDQ130_provenance.
- NP675489.RA4YuojXGEodTj299hliS1zHi8f3UN72cxAAAvLXVNmhE130_assertion description "[Leukocyte infiltration and tumor angiogenesis were assessed by immunohistochemistry with antibodies against neutrophil (Gr-1, 7/4) or macrophage-specific antigens (CD68, F4-80) and the vascular endothelial cell marker CD31, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675489.RA4YuojXGEodTj299hliS1zHi8f3UN72cxAAAvLXVNmhE130_provenance.